Arvinas, Inc. Common Stock ARVN
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-07T07:27:28.042Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T21:05:30.541059997Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-07T07:27:27.658563+00:00
Arvinas, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 4.46 | 477.8% | 47.0% | |||
| 25Δ | ||||||
| 30Δ | 6.12 | 70.3% | 8.1% | |||
| 35Δ | 6.28 | 87.0% | 8.1% | |||
| 40Δ | 6.45 | 103.6% | 8.1% | |||
| 45Δ | 6.62 | 120.3% | 8.1% | |||
| 50Δ | 6.79 | 136.9% | 8.1% | |||
| 55Δ | 6.96 | 153.5% | 8.1% | |||
| 60Δ | 7.19 | 153.2% | 7.1% | |||
| 65Δ | 5.97 | 246.0% | 15.1% | 7.44 | 147.8% | 5.8% |
| 70Δ | 5.62 | 235.7% | 12.0% | 7.68 | 142.5% | 4.6% |
| 75Δ | 5.27 | 225.3% | 8.8% | 7.93 | 137.2% | 3.3% |
| 80Δ | 4.90 | 217.0% | 6.0% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.46
- IV
- 477.8%
- B/E move
- 47.0%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.12
- IV
- 70.3%
- B/E move
- 8.1%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.28
- IV
- 87.0%
- B/E move
- 8.1%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.45
- IV
- 103.6%
- B/E move
- 8.1%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.62
- IV
- 120.3%
- B/E move
- 8.1%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.79
- IV
- 136.9%
- B/E move
- 8.1%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.96
- IV
- 153.5%
- B/E move
- 8.1%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.19
- IV
- 153.2%
- B/E move
- 7.1%
65Δ
- Pseudo strike
- 5.97
- IV
- 246.0%
- B/E move
- 15.1%
- Pseudo strike
- 7.44
- IV
- 147.8%
- B/E move
- 5.8%
70Δ
- Pseudo strike
- 5.62
- IV
- 235.7%
- B/E move
- 12.0%
- Pseudo strike
- 7.68
- IV
- 142.5%
- B/E move
- 4.6%
75Δ
- Pseudo strike
- 5.27
- IV
- 225.3%
- B/E move
- 8.8%
- Pseudo strike
- 7.93
- IV
- 137.2%
- B/E move
- 3.3%
80Δ
- Pseudo strike
- 4.90
- IV
- 217.0%
- B/E move
- 6.0%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 88.98% | |
| 70.69% | |
| 76.59% | |
| 101.31% | |
| 106.76% | |
| 108.44% | |
| 96.78% | |
| 101.08% | |
| 93.14% | |
| 99.81% |
Biotechnology
ARWR
Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.
More →ASMB
Assembly Biosciences, Inc. is a clinical-stage biotechnology company in the United States. The company is headquartered in South San Francisco, California.
More →ASND
Ascendis Pharma A / S, a biopharmaceutical company, develops therapies for unmet medical needs. The company is headquartered in Hellerup, Denmark.
More →ATNM
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation (BMT) or a type of…
More →ATOS
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered…
More →AUPH
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and markets therapies to treat various diseases with unmet medical needs in Japan and China. The company is…
More →